Stevens Capital Management LP Vertex Pharmaceuticals Inc Transaction History

Stevens Capital Management LP

$703 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 08, 2024	BUY	$407.69 - $446.08 $1.09 Million - $1.19 Million	2,668 New	2,668 $1.12 Million
Q4 2022 Feb 06, 2023	BUY	$285.76 - $321.48 $248,325 - $279,366	869 New	869 $251,000
Q4 2021 Jan 28, 2022	SELL	$177.01 - $223.45 $1.77 Million - $2.23 Million	-9,972 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $1.48 Million - $1.65 Million	8,148 Added 446.71%	9,972 $1.81 Million
Q2 2021 Aug 12, 2021	SELL	$187.49 - $221.1 $488,411 - $575,965	-2,605 Reduced 58.82%	1,824 $368,000
Q1 2021 May 11, 2021	BUY	$207.02 - $241.31 $549,017 - $639,954	2,652 Added 149.24%	4,429 $952,000
Q4 2020 Feb 08, 2021	BUY	$207.01 - $276.09 $130,623 - $174,212	631 Added 55.06%	1,777 $420,000
Q3 2020 Nov 13, 2020	SELL	$255.65 - $303.1 $4.34 Million - $5.15 Million	-16,985 Reduced 93.68%	1,146 $312,000
Q2 2020 Aug 13, 2020	BUY	$225.48 - $295.8 $4.09 Million - $5.36 Million	18,131 New	18,131 $5.26 Million
Q1 2020 Apr 21, 2020	SELL	$199.77 - $247.81 $2.92 Million - $3.63 Million	-14,636 Closed	0 $0
Q4 2019 Feb 06, 2020	SELL	$166.71 - $223.91 $2.84 Million - $3.81 Million	-17,016 Reduced 53.76%	14,636 $3.21 Million
Q3 2019 Nov 08, 2019	BUY	$166.23 - $187.09 $5.26 Million - $5.92 Million	31,652 New	31,652 $5.36 Million
Q3 2018 Nov 13, 2018	SELL	$167.73 - $192.74 $9.12 Million - $10.5 Million	-54,397 Closed	0 $0
Q2 2018 Aug 09, 2018	BUY	$145.72 - $169.96 $7.93 Million - $9.25 Million	54,397 New	54,397 $9.25 Million
Q4 2017 Feb 13, 2018	SELL	$137.28 - $155.55 $11.2 Million - $12.7 Million	-81,819 Closed	0 $0
Q3 2017 Nov 01, 2017	BUY	$148.13 - $162.24 $12.1 Million - $13.3 Million	81,819	81,819 $12.4 Million

Others Institutions Holding VRTX

# of Institutions

1,723

Shares Held

222M

Call Options Held

1.58M

Put Options Held

1.36M

Capital World Investors Los Angeles, CA

26.8M
Shares

$12.1 Billion
1.99% of portfolio
Vanguard Group Inc Valley Forge, PA

23.2M
Shares

$10.4 Billion
0.2% of portfolio
Black Rock Inc. New York, NY

21.3M
Shares

$9.6 Billion
0.23% of portfolio
State Street Corp Boston, MA

11.8M
Shares

$5.32 Billion
0.23% of portfolio
Capital Research Global Investors Los Angeles, CA

9M
Shares

$4.05 Billion
0.9% of portfolio

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Stevens Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Stevens Capital Management LP with notifications on news.

Account